Open Orphan , the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine
Open Orphan PLC (LON:ORPH) Appointment of new Director
Open Orphan PLC (LON:ORPH) Appointment of Professor Oxford as Chair of Advisory Board
With the initial focus to help guide Open Orphan in the provision of solutions to Coronavirus outbreak
Open Orphan PLC (LON:ORPH) Appointment of Group Chief Financial Officer
Cathal Friel, Executive Chairman of Open Orphan said: “I am delighted that we have appointed Leo as CFO. He has worked with Open Orphan for the past year and is
Open Orphan PLC (LON:ORPH) Upcoming Investor Events & Investor Presentation
Open Orphan (ORPH), the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine
Share Talk Bulletin Board Heroes, Monday 3rd February 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here are
Open Orphan PLC (LON:ORPH) New Corporate Presentation
Open Orphan plc (ORPH), the rapidly growing specialist pharmaceutical services company which has a focus on orphan drugs, is pleased to announce the latest copy of its investor presentation is
Open Orphan PLC (LON:ORPH) Results of Placing and Subscription
Cathal Friel, Executive Chairman of Open Orphan, said: As I said in our RNS announcement of the 20th of January, I am hugely excited by the combination of Open Orphan
Open Orphan PLC (LON:ORPH) Compulsory Acquisition of Remaining hVIVO Shares
Open Orphan plc (ORPH), the rapidly growing specialist pharmaceutical services Group which has a focus on orphan drugs, made a recommended all-equity offer (the “Offer”) on 9 December 2019 for
Open Orphan PLC (LON:ORPH) Update on Placing & Studio Interview
Open Orphan plc (ORPH), a rapidly growing specialist pharmaceutical services company which has a focus on orphan drugs, confirms that as previously announced it is currently undertaking meetings with investors
Cathal Friel, Executive Chairman of Open Orphan PLC (LON:ORPH)
Open Orphan Plc announced the completion of its acquisition of UK-based hVivo Plc on Monday, 20th January 2020.
Open Orphan PLC (LON:ORPH) Completion of Merger with hVIVO and Re-Admission
Open Orphan plc (ORPH), a rapidly growing specialist pharmaceutical services company which has a focus on orphan drugs, is pleased to announce that admission to trading on AIM and Euronext
and then 